124 related articles for article (PubMed ID: 3169110)
1. Studies of the agonist and antagonist activity of cicloprolol in man.
McCaffrey PM; Burke M; Riddell JG; Shanks RG
Eur J Clin Pharmacol; 1988; 34(6):569-75. PubMed ID: 3169110
[TBL] [Abstract][Full Text] [Related]
2. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
3. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
McCaffrey PM; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
[TBL] [Abstract][Full Text] [Related]
4. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
6. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
7. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
Hadfield SE; Slee SJ; Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):78S-81S. PubMed ID: 2572262
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
McCaffrey PM; Riddell JG; Shanks RG
Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure.
Cocco G; Alfiero R; Pouleur H
Clin Cardiol; 1992 Jan; 15(1):38-42. PubMed ID: 1347258
[TBL] [Abstract][Full Text] [Related]
10. Effect of cicloprolol in intraocular pressure in healthy volunteers.
Mekki QA; Turner P
Br J Clin Pharmacol; 1988 Jul; 26(1):89-91. PubMed ID: 2904826
[TBL] [Abstract][Full Text] [Related]
11. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic without pharmacokinetic interaction between cicloprolol, a partial beta 1-adrenoceptor agonist, and digoxin in healthy subjects.
Weber S; Kahan A; Pinquier JL; Julien J; Rosenzweig P; Bianchetti G; Morselli PL; Dessault O; De Lauture D; Strauch G
Br J Clin Pharmacol; 1990 Sep; 30(3):411-6. PubMed ID: 1977438
[TBL] [Abstract][Full Text] [Related]
13. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH
J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
[TBL] [Abstract][Full Text] [Related]
16. The pharmacodynamics of dilevalol.
Riddell JG
J Hum Hypertens; 1990 Jun; 4 Suppl 2():39-44. PubMed ID: 2370642
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect on heart rate variability of some agents acting at the beta-adrenoceptor using nonlinear scatterplot and sequence methods.
Silke B; Riddell JG
Cardiovasc Drugs Ther; 1998 Oct; 12(5):439-48. PubMed ID: 9926274
[TBL] [Abstract][Full Text] [Related]
18. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
19. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
Johnston GD; Finch MB; Shanks RG
Eur J Clin Pharmacol; 1986; 30(6):649-52. PubMed ID: 3533562
[TBL] [Abstract][Full Text] [Related]
20. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
